Today’s pharma news reflects in a rapid momentum with new oncology expansion, drug innovation and disease control initiatives
Alembic Pharmaceuticals has secured USFDA approval for its generic prucalopride tablets, drawing sharp market attention
Aster DM has announced INR a 1,315 crore investment to strengthen Karnataka healthcare through new hospitals and expanded medical facilities.
The global and Indian pharmaceutical landscape continues to evolve rapidly, driven by drug trials, financial growth and healthcare expansion
India’s pharmaceutical and healthcare sector continues to evolve rapidly, driven by regulatory shifts, investments, technological advancements, and public health initiatives
The pharmaceutical industry continues to evolve, driven by regulatory shifts, legal battles, clinical trial outcomes, strategic partnerships, and strong commercial performance
The pharmaceutical industry has undergone a fundamental shift from traditional drug discovery methods then characterized by long timelines, high costs, and high failure rates
The pharmaceutical and healthcare industry continues to evolve rapidly, driven by policy changes, strategic investments, scientific breakthroughs, and regulatory developments.
Patients using GLP-1 drugs for obesity and type 2 diabetes may have a slightly higher chance of developing hair loss, according to three new studies.
Drug development fundamentally depends on identifying the right biological target, a target typically a gene, protein, or pathway acts as the intervention point for therapy.
.jpg)
, CDSCO.jpg)
